サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629232

イオパミドール注射剤の世界市場：種類別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Iopamidol Injection Market, By Type, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
イオパミドール注射剤の世界市場：種類別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

イオパミドール注射剤の市場規模は2024年に15億9,160万米ドルとなり、2025年から2032年にかけてCAGR 4.50%で拡大

イオパミドール注射剤の市場力学

慢性疾患の有病率の上昇

がん、神経疾患、心血管疾患などの慢性疾患の増加が、イオパミドール注射剤市場を牽引する主な要因の一つです。正確な診断と治療計画を立てるために、多くの疾患では高度な画像診断技術が頻繁に必要とされます。非イオン性水溶性造影剤であるイオパミドールは、CTスキャン、血管造影、脊髄造影などさまざまな画像診断で広く使用されているため、需要が大幅に増加しています。市場を牽引するその他の要因としては、診断プロセスの精度と有効性を向上させる画像技術の開発が進んでいることが挙げられます。さらに、高齢者では慢性疾患が多いため、高齢になるほど画像診断治療の必要性が高まります。高齢者はがん、神経疾患、心血管疾患などの病気にかかりやすいため、高齢化によってイオパミドールのような造影剤の必要性が高まります。さらに、疾病の早期診断に関する知識の増加に伴う予防医療の増加も、市場拡大の主な要因となっています。

イオパミドール注射剤市場：主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約4.50%のCAGRで毎年成長すると推定されます。

市場セグメンテーションに基づくと、9 gl/30 mLが2024年に最大市場シェアを示すと予測されました。

用途別では、病院が2024年の主要用途でした。

地域別では、北米が2024年の売上高でトップ

イオパミドール注射剤市場：セグメンテーション分析

イオパミドール注射剤の世界市場は、タイプ、用途、地域によって区分されます。

タイプ別では、市場は2つのカテゴリーに分別される：9gI/30mLと11.1gI/30mLです。コンピュータ断層撮影 (CT) スキャンや血管造影などの画像診断で幅広く使用されているため、イオパミドール注射剤市場の9gI/30mLカテゴリーは大きく拡大しています。患者リスクを低減しながら画像コントラストを最大化する理想的なヨウ素含量のため、この濃度が特に好まれています。このカテゴリーの採用は、心血管疾患や神経疾患などの慢性疾患の有病率の上昇により、正確で非侵襲的な診断ソリューションに対する需要が高まっていることが、さらに拍車をかけています。

用途別に見ると、市場は病院、クリニック、その他に分けられます。診断・治療サービスが充実していることから、病院が最大のカテゴリーを占めています。イオパミドール注射剤は、患者数が多く、高度な画像診断機器を備えているため、病院で使用されることが多いです。このセグメントのイオパミドール需要は、病院で行われる画像診断の件数の増加や慢性疾患の罹患率が牽引しています。市場の拡大は、病院が正確で効果的な診断サービスを提供することに重点を置いていることも後押ししています。

イオパミドール注射剤市場：地域別分析

イオパミドール注射剤市場は、画像診断を必要とするがんや心血管疾患などの慢性疾患の罹患率が上昇していることから、北米地域で大きく拡大すると予測されています。北米地域で市場が拡大しているのは、医療インフラが整備されており、最新の画像診断技術の採用率が高いためです。さらに、同地域の拡大は、画像診断研究のための資金調達、政府の支援策、主要な市場競合企業の存在が後押ししています。

欧州のイオパミドール注射剤市場は、高齢者人口の増加と画像診断技術の向上により安定した成長が見込まれています。同市場は、ドイツ、英国、フランスといった国々が高度な医療システムと高い医療費によって牽引しています。さらに市場拡大の原動力となっているのは、最先端の画像処理技術の導入と非侵襲的診断技術の重視の高まりです。また、イオパミドールのような造影剤の安全性と有効性を保証する厳格な規制の枠組みもこの地域の利点となっており、欧州全域で画像診断用途での使用が増加しています。

イオパミドール注射剤市場：競合情勢

GE Healthcare、Bayer AG、Aviceena Pharmaceutical LLC、Sun Pharmaceutical Industries Ltd.、Bracco Diagnostics Inc.、Sanochemia Pharmazeutika GmbHなどの主要競合が、研究開発、製品革新、戦略的提携に積極的に取り組んでおり、イオパミドール注射剤市場の競合情勢を決定付けています。各企業は、製品ラインの拡大、製品の安全性と有効性の向上、M&Aによる市場シェアの拡大に注力しています。競合情勢は、技術の進歩、規制のクリアランス、患者や医療提供者の進化するニーズへの適応能力など、多くの要因によって左右されます。顧客を増やし競争優位に立つため、業界大手はマーケティング戦略や流通戦略にも投資しています。

目次

第1章 イオパミドール注射剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 イオパミドール注射剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 イオパミドール注射剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 イオパミドール注射剤市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 イオパミドール注射剤の市場情勢

  • イオパミドール注射剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 イオパミドール注射剤市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 9gI/30mL
    • 11.1gI/30mL

第8章 イオパミドール注射剤市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 病院
    • クリニック
    • その他

第9章 イオパミドール注射剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：イオパミドール注射剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GE Healthcare
    • Bayer AG
    • Aviceena Pharmaceutical LLC
    • Sun Pharmaceutical Industries Ltd.
    • Bracco Diagnostics Inc.
    • Sanochemia Pharmazeutika GmbH
    • Guerbet Group
    • Jiangsu Hengrui Medicine Co., Ltd.
    • Mahe Medical USA, LLC
    • Hunan Hansen Pharmaceutical Co., Ltd.
    • Taejoon Pharm Co., Ltd.
    • Tianjin Pharmaceutical Holdings Co., Ltd.
    • Others

第11章 AnalystViewの全方位的分析

目次
Product Code: ANV4484

REPORT HIGHLIGHT

Iopamidol Injection Market size was valued at US$ 1,591.6 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

The non-ionic, water-soluble contrast agent iopamidol injection is mostly used in diagnostic imaging tests such as computed tomography (CT) scans. It is required in order to improve the visibility of internal organs and structures, which facilitates precise diagnosis and treatment planning. This diagnostic breakthrough is especially important for musculoskeletal, neurological, and cardiovascular exams. The market is driven by a number of factors, such as the growing incidence of chronic illnesses like neurological and cardiovascular conditions, the growing need for less invasive diagnostic techniques, and developments in imaging technology. The world's population is getting older, which increases demand as age-related illnesses become more common. The creation of low-dose imaging systems and higher requirements for image quality are two examples of recent technological developments that offer substantial prospects for market growth. Despite these advantages, the market is confronted with obstacles that could hinder its expansion, such as strict regulatory requirements and possible adverse effects linked to iodine-based contrast agents. High prices and restricted supply in developing areas also pose limitations. One promising area of research and development is the creation of safer, more affordable agents with fewer side effects and improved efficacy.

Iopamidol Injection Market- Market Dynamics

Rising Prevalence of Chronic Illness

The growing cases of chronic illnesses like cancer, neurological disorders, and cardiovascular disorders is one of the main reasons driving the market for iopamidol injections. In order to accurately diagnose and plan for therapy, many disorders frequently require sophisticated imaging techniques. Its demand is greatly increased by the widespread use of iopamidol, a non-ionic, water-soluble contrast agent, in various imaging modalities, including CT scans, angiography, and myelography. Additional factors driving the market include ongoing developments in imaging technology that improve the precision and effectiveness of diagnostic processes. Moreover, the necessity for diagnostic imaging treatments increases as people age because chronic diseases are more common in older adults. Because they are more vulnerable to diseases like cancer, neurological problems, and cardiovascular ailments, the aged population increases the need for contrast agents like iopamidol. Furthermore, the rise in preventive healthcare practices that follow the increased knowledge of early disease diagnosis is a major factor driving market expansion.

Iopamidol Injection Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on type segmentation, the 9 g I/30 mL was predicted to show maximum market share in the year 2024

Based on application segmentation, hospitals were the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Iopamidol Injection Market- Segmentation Analysis:

The Global Iopamidol Injection Market is segmented on the basis of Type, application, and Region.

On the basis of type, the market is segregated into two categories: 9 g I/ 30 mL and 11.1 g I/ 30 mL. Due to its extensive use in diagnostic imaging procedures, including computed tomography (CT) scans and angiography, the 9 g I/30 mL category of the iopamidol injection market is expanding significantly. Because of its ideal iodine content, which maximizes imaging contrast while lowering patient risk, this concentration is especially preferred. The adoption of this category has been further fueled by the growing demand for precise and non-invasive diagnostic solutions due to the rising prevalence of chronic diseases, such as cardiovascular and neurological ailments.

Based on application, the market is divided into Hospitals, Clinics, and Others. Due to their extensive array of diagnostic and therapeutic services, hospitals make up the largest category. Iopamidol injections are often used in hospitals because of their high patient volume and sophisticated imaging equipment. This segment's demand for Iopamidol is driven by the growing number of imaging procedures conducted in hospitals and the incidence of chronic disorders. Market expansion is further aided by hospitals' emphasis on offering precise and effective diagnostic services.

Iopamidol Injection Market- Geographical Insights

The market for iopamidol injection is anticipated to expand significantly in the North American area as a result of the rising incidence of chronic illnesses like cancer and cardiovascular diseases that call for diagnostic imaging. The market is expanding in North American region due to the well-established healthcare infrastructure and the high rate of adoption of modern imaging technologies. Additionally, the region's expansion is aided by financing for diagnostic imaging research, supportive government initiatives, and the presence of major market competitors.

The iopamidol injection market in Europe is expected to grow steadily due to an older population and a rise in diagnostic imaging techniques. The market is led by nations like Germany, the United Kingdom, and France because of their sophisticated healthcare systems and high healthcare spending. Further driving market expansion are the incorporation of state-of-the-art imaging technology and the increasing emphasis on non-invasive diagnostic techniques. Strict regulatory frameworks that guarantee the safety and effectiveness of contrast agents like iopamidol also benefit the region, increasing the use of these drugs in diagnostic imaging applications throughout Europe.

Iopamidol Injection Market- Competitive Landscape:

Several major competitors such as GE Healthcare, Bayer AG, Aviceena Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd., Bracco Diagnostics Inc., Sanochemia Pharmazeutika GmbH, and others are actively engaged in R&D, product innovation, and strategic partnerships define the competitive landscape of the Iopamidol Injection market. Businesses are concentrating on growing their product lines, making their products safer and more effective, and boosting their market share through mergers and acquisitions. The competitive landscape is driven by a number of factors, including technological advancements, regulatory clearances, and the ability to adjust to the evolving needs of patients and healthcare providers. To increase their clientele and gain a competitive edge, major industry players are also investing in marketing and distribution strategies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IOPAMIDOL INJECTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Bayer AG
  • Aviceena Pharmaceutical LLC
  • Sun Pharmaceutical Industries Ltd.
  • Bracco Diagnostics Inc.
  • Sanochemia Pharmazeutika GmbH
  • Guerbet Group
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Mahe Medical USA, LLC
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Taejoon Pharm Co., Ltd.
  • Tianjin Pharmaceutical Holdings Co., Ltd.
  • Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • 9 g I/ 30 mL
  • 11.1 g I/ 30 mL

GLOBAL IOPAMIDOL INJECTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Iopamidol Injection Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Iopamidol Injection Market Snippet by Type
    • 2.1.2. Iopamidol Injection Market Snippet by Application
    • 2.1.3. Iopamidol Injection Market Snippet by Country
    • 2.1.4. Iopamidol Injection Market Snippet by Region
  • 2.2. Competitive Insights

3. Iopamidol Injection Key Market Trends

  • 3.1. Iopamidol Injection Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Iopamidol Injection Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Iopamidol Injection Market Opportunities
  • 3.4. Iopamidol Injection Market Future Trends

4. Iopamidol Injection Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Iopamidol Injection Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Iopamidol Injection Market Landscape

  • 6.1. Iopamidol Injection Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Iopamidol Injection Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. 9 g I/ 30 mL
    • 7.1.3. 11.1 g I/ 30 mL

8. Iopamidol Injection Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Clinics
    • 8.1.4. Others

9. Iopamidol Injection Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Iopamidol Injection Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Iopamidol Injection Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Iopamidol Injection Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Iopamidol Injection Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Iopamidol Injection Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Iopamidol Injection Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. GE Healthcare
    • 10.2.2. Bayer AG
    • 10.2.3. Aviceena Pharmaceutical LLC
    • 10.2.4. Sun Pharmaceutical Industries Ltd.
    • 10.2.5. Bracco Diagnostics Inc.
    • 10.2.6. Sanochemia Pharmazeutika GmbH
    • 10.2.7. Guerbet Group
    • 10.2.8. Jiangsu Hengrui Medicine Co., Ltd.
    • 10.2.9. Mahe Medical USA, LLC
    • 10.2.10. Hunan Hansen Pharmaceutical Co., Ltd.
    • 10.2.11. Taejoon Pharm Co., Ltd.
    • 10.2.12. Tianjin Pharmaceutical Holdings Co., Ltd.
    • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us